Frequently Asked Questions - Metabolic Research
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist peptide widely studied for its effects on blood sugar regulation, appetite, and metabolism. Pepti supplies Semaglutide 5mg for metabolic research in Canada, quality tested at a local Canadian facility and sold strictly for laboratory use, not for personal weight loss or medical treatment.
How is tirzepatide different from semaglutide?
Tirzepatide is a dual GIP and GLP-1 receptor agonist, while semaglutide targets only the GLP-1 receptor. This difference lets researchers compare single and dual incretin pathways in metabolic studies. Pepti stocks Tirzepatide 10mg and Semaglutide 5mg for research in Canada, both purity tested at a local Canadian facility.
Why is retatrutide called a triple agonist?
Retatrutide is called a triple agonist because it acts on three receptors, GLP-1, GIP, and glucagon, unlike single or dual incretin peptides. This makes it a key compound in advanced metabolic research. Pepti offers Retatrutide in 10mg and 20mg vials for researchers in Canada, each batch tested locally.
Can research peptides be used for weight loss?
No, research peptides such as semaglutide, tirzepatide, and retatrutide from Pepti are sold in Canada only for laboratory research, not for human use or weight loss. Anyone looking for weight management support should talk to a licensed doctor about Health Canada-approved prescription options instead of using research-grade compounds.
Where can researchers buy metabolic peptides in Canada?
Researchers can buy metabolic peptides in Canada from Pepti, which carries Semaglutide, Tirzepatide, Retatrutide, Mazdutide, Cagrilintide, and AOD-9604. Each product is purity tested at a local Canadian facility, orders over $150 ship free within 2 days, and tracking details are sent within 24 hours of payment.







